Patient education: An efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients

Chiao Yin Sun, Kuo Chuan Chang, Sue Hsien Chen, Chiz Tzung Chang, Mai Szu Wu

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background. Hemodialysis and phosphate (P) binder therapy are the major methods to reduce the phosphate level in dialysis patients. However, dietary P restriction is necessary for adequate control. The successful dietary control is based on patient compliance. Patient education is the best method to assure the knowledge and drive of dietary control, which are the key features for patient compliance. The aim of the study is to investigate quantitatively the effect of patient education on serum P levels in hyperphosphatemic hemodialysis patients. Methods. We conducted a prospective self-control study. Fifty hemodialysis patients with a pre-dialysis serum P level greater than 6.0 mg/dL were studied. Intensified patient education was given. Serum P, calcium (Ca), and intact parathyroid hormone (iPTH) were evaluated before and one month after patient education. Results. Thirty-six (72%) patients had improved pre-dialysis P level (pre-education: 7.50 ± 1.33; post-education: 5.85 ± 1.20 mg/dL, p <0.001) and Ca x P product (pre-education: 68.17 ± 12.70; post-education: 54.70 ± 11.87 mg2/dL2, p <0.001). The effect lasted for at least three months. There is no significant change on calcium levels. The only predictor of a successful patient education is the iPTH level (improved: 348.8 ± 277.6; non-improved: 668.0 ± 674.1 ng/mL, p = 0.021). Conclusions. Patient education could be helpful and efficient in hyperphosphatemic control in dialysis patients. The patient education should be given before the serum iPTH level getting high.

Original languageEnglish
Pages (from-to)57-62
Number of pages6
JournalRenal Failure
Volume30
Issue number1
DOIs
Publication statusPublished - Jan 2008
Externally publishedYes

Fingerprint

Hyperphosphatemia
Patient Education
Renal Dialysis
Dialysis
Parathyroid Hormone
Education
Patient Compliance
Calcium
Serum
Therapeutics
Phosphates

Keywords

  • Dialysis
  • Hyperphosphatemia
  • Patient education

ASJC Scopus subject areas

  • Nephrology

Cite this

Patient education : An efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients. / Sun, Chiao Yin; Chang, Kuo Chuan; Chen, Sue Hsien; Chang, Chiz Tzung; Wu, Mai Szu.

In: Renal Failure, Vol. 30, No. 1, 01.2008, p. 57-62.

Research output: Contribution to journalArticle

Sun, Chiao Yin ; Chang, Kuo Chuan ; Chen, Sue Hsien ; Chang, Chiz Tzung ; Wu, Mai Szu. / Patient education : An efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients. In: Renal Failure. 2008 ; Vol. 30, No. 1. pp. 57-62.
@article{e7291ce3bde44aabb3a2bdf6d1f9b156,
title = "Patient education: An efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients",
abstract = "Background. Hemodialysis and phosphate (P) binder therapy are the major methods to reduce the phosphate level in dialysis patients. However, dietary P restriction is necessary for adequate control. The successful dietary control is based on patient compliance. Patient education is the best method to assure the knowledge and drive of dietary control, which are the key features for patient compliance. The aim of the study is to investigate quantitatively the effect of patient education on serum P levels in hyperphosphatemic hemodialysis patients. Methods. We conducted a prospective self-control study. Fifty hemodialysis patients with a pre-dialysis serum P level greater than 6.0 mg/dL were studied. Intensified patient education was given. Serum P, calcium (Ca), and intact parathyroid hormone (iPTH) were evaluated before and one month after patient education. Results. Thirty-six (72{\%}) patients had improved pre-dialysis P level (pre-education: 7.50 ± 1.33; post-education: 5.85 ± 1.20 mg/dL, p <0.001) and Ca x P product (pre-education: 68.17 ± 12.70; post-education: 54.70 ± 11.87 mg2/dL2, p <0.001). The effect lasted for at least three months. There is no significant change on calcium levels. The only predictor of a successful patient education is the iPTH level (improved: 348.8 ± 277.6; non-improved: 668.0 ± 674.1 ng/mL, p = 0.021). Conclusions. Patient education could be helpful and efficient in hyperphosphatemic control in dialysis patients. The patient education should be given before the serum iPTH level getting high.",
keywords = "Dialysis, Hyperphosphatemia, Patient education",
author = "Sun, {Chiao Yin} and Chang, {Kuo Chuan} and Chen, {Sue Hsien} and Chang, {Chiz Tzung} and Wu, {Mai Szu}",
year = "2008",
month = "1",
doi = "10.1080/08860220701742047",
language = "English",
volume = "30",
pages = "57--62",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Patient education

T2 - An efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients

AU - Sun, Chiao Yin

AU - Chang, Kuo Chuan

AU - Chen, Sue Hsien

AU - Chang, Chiz Tzung

AU - Wu, Mai Szu

PY - 2008/1

Y1 - 2008/1

N2 - Background. Hemodialysis and phosphate (P) binder therapy are the major methods to reduce the phosphate level in dialysis patients. However, dietary P restriction is necessary for adequate control. The successful dietary control is based on patient compliance. Patient education is the best method to assure the knowledge and drive of dietary control, which are the key features for patient compliance. The aim of the study is to investigate quantitatively the effect of patient education on serum P levels in hyperphosphatemic hemodialysis patients. Methods. We conducted a prospective self-control study. Fifty hemodialysis patients with a pre-dialysis serum P level greater than 6.0 mg/dL were studied. Intensified patient education was given. Serum P, calcium (Ca), and intact parathyroid hormone (iPTH) were evaluated before and one month after patient education. Results. Thirty-six (72%) patients had improved pre-dialysis P level (pre-education: 7.50 ± 1.33; post-education: 5.85 ± 1.20 mg/dL, p <0.001) and Ca x P product (pre-education: 68.17 ± 12.70; post-education: 54.70 ± 11.87 mg2/dL2, p <0.001). The effect lasted for at least three months. There is no significant change on calcium levels. The only predictor of a successful patient education is the iPTH level (improved: 348.8 ± 277.6; non-improved: 668.0 ± 674.1 ng/mL, p = 0.021). Conclusions. Patient education could be helpful and efficient in hyperphosphatemic control in dialysis patients. The patient education should be given before the serum iPTH level getting high.

AB - Background. Hemodialysis and phosphate (P) binder therapy are the major methods to reduce the phosphate level in dialysis patients. However, dietary P restriction is necessary for adequate control. The successful dietary control is based on patient compliance. Patient education is the best method to assure the knowledge and drive of dietary control, which are the key features for patient compliance. The aim of the study is to investigate quantitatively the effect of patient education on serum P levels in hyperphosphatemic hemodialysis patients. Methods. We conducted a prospective self-control study. Fifty hemodialysis patients with a pre-dialysis serum P level greater than 6.0 mg/dL were studied. Intensified patient education was given. Serum P, calcium (Ca), and intact parathyroid hormone (iPTH) were evaluated before and one month after patient education. Results. Thirty-six (72%) patients had improved pre-dialysis P level (pre-education: 7.50 ± 1.33; post-education: 5.85 ± 1.20 mg/dL, p <0.001) and Ca x P product (pre-education: 68.17 ± 12.70; post-education: 54.70 ± 11.87 mg2/dL2, p <0.001). The effect lasted for at least three months. There is no significant change on calcium levels. The only predictor of a successful patient education is the iPTH level (improved: 348.8 ± 277.6; non-improved: 668.0 ± 674.1 ng/mL, p = 0.021). Conclusions. Patient education could be helpful and efficient in hyperphosphatemic control in dialysis patients. The patient education should be given before the serum iPTH level getting high.

KW - Dialysis

KW - Hyperphosphatemia

KW - Patient education

UR - http://www.scopus.com/inward/record.url?scp=38349120742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349120742&partnerID=8YFLogxK

U2 - 10.1080/08860220701742047

DO - 10.1080/08860220701742047

M3 - Article

C2 - 18197544

AN - SCOPUS:38349120742

VL - 30

SP - 57

EP - 62

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 1

ER -